Omega-6 and Omega-3 Fatty Acid Levels Inversely Tied to Cancer Incidence
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online Oct. 17 in the International Journal of Cancer.
Yuchen Zhang, from the University of Georgia in Athens, and colleagues investigated the associations of plasma omega-3 and omega-6 PUFAs with the incidence of cancer (overall and 19 site-specific cancers). The analysis included 253,138 eligible U.K. Biobank participants followed for 12.9 years.
The researchers found that both omega-6 and omega-3 as percentages of total fatty acids were inversely associated with overall cancer incidence (hazard ratios [95 percent confidence intervals] per standard deviation [SD], 0.98 [0.96 to 0.99] and 0.99 [0.97 to 1.00], respectively). Fourteen of the 19 site-specific cancers available were associated with omega-6 percentage and five were associated with omega-3 percentage, all indicating inverse associations, with the exception that prostate cancer was positively associated with omega-3 percentage (hazard ratio per SD, 1.03; 95 percent confidence interval, 1.01 to 1.05).
"Higher omega-3 and omega-6 levels were associated with lower rates of cancer," Zhang said in a statement. "These findings suggest that the average person should focus on getting more of these fatty acids in their diets."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
CRC as First of Multiple Primary Malignancies Tied to Better Outcomes Than CRC as Only Malignancy
THURSDAY, June 26, 2025 -- Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the first of multiple primary...
Two-Hour Observation Probably Safe for Most Children With Anaphylaxis
THURSDAY, June 26, 2025 -- For most children who present to an emergency department with an acute allergic reaction requiring epinephrine, a two-hour observation period is...
CT Perfusion and CT Angiography Not Useful as Standalone Tests for Establishing Death by Neurologic Criteria
THURDAY, June 26, 2025 -- Neither computed tomography (CT) perfusion nor CT angiography meet the prespecified validation threshold as an ancillary test for death by neurologic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.